Please enable JS

Medical Marketing & Media – Biosimilar uptake will require companies to tell a trustworthy backstory

3/ 12

ARTICLE DETAILS

AUTHOR: 50SN Staff

DATE: Mar 12, 2015

TAGS:

SHARE ON: Twitter - Facebook - LinkedIn

Medical Marketing & Media – Biosimilar uptake will require companies to tell a trustworthy backstory

StevePhotoNovartis still has to win a patent-infringement lawsuit before it can sell Zarxio, the first biosimilar to receive FDA approval, but experts and advocates indicate the potential rollout of the drug is less important than the fact that the approval has smoothed the way for the four biosimilar applications in front of the FDA.

Read More